Gilbert & Cook’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.31M Sell
3,960
-58
-1% -$19.7K 0.17% 54
2025
Q4
$1.6M Sell
4,018
-1,490
-27% -$659K 0.2% 45
2025
Q3
$2.51M Buy
5,508
+1,514
+38% +$617K 0.32% 24
2025
Q2
$1.3M Buy
3,994
+90
+2% +$24.9K 0.18% 55
2025
Q1
$1.05M Hold
3,904
0.15% 60
2024
Q4
$919K Sell
3,904
-20
-0.5% -$5.26K 0.13% 74
2024
Q3
$1.08M Sell
3,924
-137
-3% -$35.7K 0.15% 65
2024
Q2
$987K Sell
4,061
-424
-9% -$66.9K 0.14% 65
2024
Q1
$670K Buy
4,485
+42
+0.9% +$7.01K 0.09% 106
2023
Q4
$850K Buy
4,443
+317
+8% +$54K 0.12% 77
2023
Q3
$731K Buy
4,126
+2,766
+203% +$528K 0.12% 82
2023
Q2
$258K Buy
+1,360
New +$270K 0.04% 184

Other funds holding ALNY